药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Talinolol
The therapeutic efficacy of Talinolol can be increased when used in combination with Linagliptin.
Tetracosactide
Celiprolol
The therapeutic efficacy of Celiprolol can be increased when used in combination with Linagliptin.
Tetracosactide
Deflazacort
The serum concentration of Linagliptin can be increased when it is combined with Deflazacort.
Tetracosactide
Acetyldigoxin
Linagliptin may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
Tetracosactide
Metildigoxin
Linagliptin may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
Tetracosactide
Erdafitinib
The serum concentration of Linagliptin can be increased when it is combined with Erdafitinib.
Tetracosactide
Siponimod
The risk or severity of adverse effects can be increased when Linagliptin is combined with Siponimod.
Tetracosactide
Emapalumab
The metabolism of Linagliptin can be increased when combined with Emapalumab.
Tetracosactide
Siltuximab
The metabolism of Linagliptin can be increased when combined with Siltuximab.
Tetracosactide
Secukinumab
The metabolism of Linagliptin can be increased when combined with Secukinumab.
Tetracosactide
Certolizumab pegol
The metabolism of Linagliptin can be increased when combined with Certolizumab pegol.
Tetracosactide
Golimumab
The metabolism of Linagliptin can be increased when combined with Golimumab.
Tetracosactide
Rilonacept
The metabolism of Linagliptin can be increased when combined with Rilonacept.
Tetracosactide
Tocilizumab
The metabolism of Linagliptin can be increased when combined with Tocilizumab.
Tetracosactide
Canakinumab
The metabolism of Linagliptin can be increased when combined with Canakinumab.
Tetracosactide
Afelimomab
The metabolism of Linagliptin can be increased when combined with Afelimomab.
Tetracosactide
Tetrandrine
The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Linagliptin.
Tetracosactide
Lomerizine
The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Linagliptin.
Tetracosactide
Emopamil
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Linagliptin.
Tetracosactide
Dexverapamil
The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Linagliptin.